JPS52148060A - 17 betaaester of testosterone and alphaa dihydrotestosterone - Google Patents
17 betaaester of testosterone and alphaa dihydrotestosteroneInfo
- Publication number
- JPS52148060A JPS52148060A JP6170477A JP6170477A JPS52148060A JP S52148060 A JPS52148060 A JP S52148060A JP 6170477 A JP6170477 A JP 6170477A JP 6170477 A JP6170477 A JP 6170477A JP S52148060 A JPS52148060 A JP S52148060A
- Authority
- JP
- Japan
- Prior art keywords
- betaaester
- alphaa
- dihydrotestosterone
- testosterone
- alphaa dihydrotestosterone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0025—Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/691,103 US4098802A (en) | 1975-02-18 | 1976-05-28 | Oral pharmaceutical preparation having androgenic activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS52148060A true JPS52148060A (en) | 1977-12-08 |
| JPS6145637B2 JPS6145637B2 (en) | 1986-10-08 |
Family
ID=24775172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6170477A Granted JPS52148060A (en) | 1976-05-28 | 1977-05-25 | 17 betaaester of testosterone and alphaa dihydrotestosterone |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS52148060A (en) |
| AR (1) | AR214323A1 (en) |
| BE (1) | BE855163A (en) |
| CH (1) | CH627761A5 (en) |
| DE (1) | DE2723876C2 (en) |
| DK (1) | DK146096C (en) |
| ES (1) | ES459230A1 (en) |
| FI (1) | FI57597C (en) |
| FR (1) | FR2352832A1 (en) |
| GB (1) | GB1567515A (en) |
| NL (1) | NL7705790A (en) |
| SE (1) | SE425493B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011519846A (en) * | 2008-04-28 | 2011-07-14 | ダイアーナル リミテッド | Lipid composition |
| JP2016514706A (en) * | 2013-03-15 | 2016-05-23 | リポカイン インコーポレーテッド | Lipobalance long chain testosterone ester for oral delivery |
| US9943527B2 (en) | 2010-11-30 | 2018-04-17 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US10561615B2 (en) | 2010-12-10 | 2020-02-18 | Lipocine Inc. | Testosterone undecanoate compositions |
| US11433083B2 (en) | 2010-11-30 | 2022-09-06 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US11559530B2 (en) | 2016-11-28 | 2023-01-24 | Lipocine Inc. | Oral testosterone undecanoate therapy |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2415349A1 (en) * | 2000-08-23 | 2002-02-28 | Akzo Nobel N.V. | Testosterone ester formulation for human use |
| JO2505B1 (en) | 2003-03-14 | 2009-10-05 | باير شيرنغ فارما اكتنجيسيلشافت | method and pharmaceutical compositions for reliable achievements of acceptable serum testosterone levels |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL189235C (en) * | 1974-02-28 | 1993-02-16 | Akzo Nv | METHOD FOR THE PREPARATION OF AN ORAL PHARMACEUTICAL PREPARATION WITH ANDROGENIC ACTION |
-
1977
- 1977-05-20 GB GB2131477A patent/GB1567515A/en not_active Expired
- 1977-05-24 CH CH640477A patent/CH627761A5/en not_active IP Right Cessation
- 1977-05-25 JP JP6170477A patent/JPS52148060A/en active Granted
- 1977-05-26 FI FI771684A patent/FI57597C/en not_active IP Right Cessation
- 1977-05-26 FR FR7716182A patent/FR2352832A1/en active Granted
- 1977-05-26 DE DE19772723876 patent/DE2723876C2/en not_active Expired
- 1977-05-26 NL NL7705790A patent/NL7705790A/en not_active Application Discontinuation
- 1977-05-27 ES ES459230A patent/ES459230A1/en not_active Expired
- 1977-05-27 BE BE178016A patent/BE855163A/en not_active IP Right Cessation
- 1977-05-27 SE SE7706235A patent/SE425493B/en not_active IP Right Cessation
- 1977-05-27 AR AR26780777A patent/AR214323A1/en active
- 1977-05-27 DK DK236877A patent/DK146096C/en not_active IP Right Cessation
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011519846A (en) * | 2008-04-28 | 2011-07-14 | ダイアーナル リミテッド | Lipid composition |
| US9012436B2 (en) | 2008-04-28 | 2015-04-21 | Diurnal Limited | Lipid composition |
| US10973833B2 (en) | 2010-11-30 | 2021-04-13 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9943527B2 (en) | 2010-11-30 | 2018-04-17 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9949985B2 (en) | 2010-11-30 | 2018-04-24 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US10226473B2 (en) | 2010-11-30 | 2019-03-12 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US10799513B2 (en) | 2010-11-30 | 2020-10-13 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US10881671B2 (en) | 2010-11-30 | 2021-01-05 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US11311555B2 (en) | 2010-11-30 | 2022-04-26 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US11364250B2 (en) | 2010-11-30 | 2022-06-21 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US11364249B2 (en) | 2010-11-30 | 2022-06-21 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US11433083B2 (en) | 2010-11-30 | 2022-09-06 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US10561615B2 (en) | 2010-12-10 | 2020-02-18 | Lipocine Inc. | Testosterone undecanoate compositions |
| JP2016514706A (en) * | 2013-03-15 | 2016-05-23 | リポカイン インコーポレーテッド | Lipobalance long chain testosterone ester for oral delivery |
| US11559530B2 (en) | 2016-11-28 | 2023-01-24 | Lipocine Inc. | Oral testosterone undecanoate therapy |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2352832B1 (en) | 1980-07-11 |
| GB1567515A (en) | 1980-05-14 |
| ES459230A1 (en) | 1978-11-16 |
| FI57597C (en) | 1980-09-10 |
| DE2723876A1 (en) | 1977-12-15 |
| SE7706235L (en) | 1977-11-29 |
| FI57597B (en) | 1980-05-30 |
| DK236877A (en) | 1977-11-29 |
| DK146096B (en) | 1983-06-27 |
| AR214323A1 (en) | 1979-05-31 |
| JPS6145637B2 (en) | 1986-10-08 |
| CH627761A5 (en) | 1982-01-29 |
| FI771684A (en) | 1977-11-29 |
| FR2352832A1 (en) | 1977-12-23 |
| DK146096C (en) | 1983-11-21 |
| DE2723876C2 (en) | 1986-10-30 |
| BE855163A (en) | 1977-11-28 |
| NL7705790A (en) | 1977-11-30 |
| SE425493B (en) | 1982-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5289649A (en) | Compositions and process | |
| JPS5395989A (en) | Substituted 11thienyl and furyll 2*3*4*55tetrahydroo1hh33benzazepine compound | |
| JPS52100446A (en) | Compositions and process | |
| JPS5293535A (en) | Haymaker having functions of mowering and drying | |
| JPS53141292A (en) | Novel imidazoazine and * imidazodiazine | |
| ZA772084B (en) | Testosterone 5a-reductase inhibitors | |
| JPS51131880A (en) | 11*3*3*33triarylpropyl**44 phenyll44piperidinemethanol and analogous compounds | |
| GB1539021A (en) | Arrangements and devices for facilitating the movement of luggage | |
| JPS5289650A (en) | Compositions and process | |
| JPS52148060A (en) | 17 betaaester of testosterone and alphaa dihydrotestosterone | |
| JPS52139040A (en) | 22 and 33substituted enekephlin | |
| JPS5289648A (en) | Compositions and process | |
| JPS54106462A (en) | 33*nnacyllnnarylamino**gammaabutyrolactone and gammaabutyrothiolactone | |
| JPS52153975A (en) | Dihydroo and tetrahydroo iminothazidine | |
| JPS52133954A (en) | Compositions and process | |
| JPS53132582A (en) | 33*11piperadinyl**1*2*44benzotriazine and nnoxide | |
| JPS52133995A (en) | 1*2*44thiadiazinone and its preparation and application thereof | |
| JPS527966A (en) | 99hydroxyy7*8*9*100tetrahydroo 6hhdibenzo*b**d*bilanes and bilanones | |
| PH13879A (en) | D-homo steroid and composition containing the same | |
| JPS5365853A (en) | 15 * 166dihydroxyprostaglandin and like | |
| JPS52108979A (en) | 33substitutedd55phenyll55pyridylhydantoin and antiiarrhythmic agents | |
| JPS52100449A (en) | Compositions and process | |
| JPS52103324A (en) | Compound material of antiiabrasion and shockkresisting | |
| PH14030A (en) | Derivatives of 2-iminothiazolidine and 2-iminothiazoline | |
| JPS52100448A (en) | Compositions and process |